From: Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population
Index Score | EQ VAS | |||
---|---|---|---|---|
n (%) | Mean (SD) | n (%) | Mean (SD) | |
All | 676 | 0.924 (0.117) | 674 | 87.4 (10.9) |
Age | ||||
18–34 | 236 (34.9) | 0.916 (0.111) | 236 (35.0) | 88.4 (9.2) |
35–64 | 371 (54.9) | 0.927 (0.122) | 370 (54.9) | 86.5 (12.1) |
65+ | 69 (10.2) | 0.936 (0.106) | 68 (10.1) | 88.8 (9.2) |
Gender | ||||
Female | 495 (73.2) | 0.920 (0.113) | 495 (73.4) | 87.2 (11.1) |
Male | 181 (26.8) | 0.935 (0.125) | 179 (26.6) | 87.9 (10.3) |
Race/Ethnicity | ||||
White or Caucasian | 486 (71.9) | 0.921 (0.118) | 484 (71.8) | 87.1 (10.7) |
Black or African American | 32 (4.7) | 0.918 (0.166) | 32 (4.8) | 82.7 (14.8) |
Hispanic | 85 (12.6) | 0.930 (0.105) | 85 (12.6) | 88.4 (11.4) |
Asian | 35 (5.2) | 0.969 (0.051) | 35 (5.2) | 89.9 (9.0) |
Patient Refused | 16 (2.4) | 0.927 (0.096) | 16 (2.4) | 86.6 (10.2) |
Other | 22 (3.3) | 0.899 (0.131) | 22 (3.3) | 91.7 (9.1) |
Chronic conditions | ||||
Asthma or Chronic Lung Disease | 58 (8.6) | 0.873 (0.152) | 57 (8.5) | 81.7 (14.0) |
Diabetes | 32 (4.7) | 0.887 (0.131) | 32 (4.8) | 82.8 (11.1) |
Hypertension | 76 (11.2) | 0.887 (0.158) | 75 (11.1) | 83.1 (12.2) |
Extreme obesity | 23 (3.4) | 0.782 (0.258) | 23 (3.4) | 77.0 (13.7) |
Immunocompromised Conditions or Weakened Immune System a | 27 (4.0) | 0.889 (0.134) | 27 (4.0) | 78.6 (15.2) |